Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Egis Gyógyszergyár Zrt currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 2 distinct examiners and 2 distinct art units. This suggests that the company's pharmaceutical research is being examined across different specialized groups within the patent office.
The busiest examiner for the portfolio is STEVENS, MARK V, who is responsible for 1 busiest examiner pending office action. Because the 2 pending office actions are split between different examiners, no single official holds a majority of the workload. This distribution requires the applicant to adapt to the different examination styles of each individual.
The involvement of 2 distinct art units means that the company must navigate the specific guidelines and precedents of different organizational groups. Each active case will be subject to the unique standards of its respective unit. Practitioners must coordinate their responses to ensure that arguments remain effective across both specialized groups.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BARSKY, JARED | 1 | 50.2% | +22.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18273700 | TOPICAL FORMULATION CONTAINING DISPERSED PREGABALIN | BARSKY, JARED | 14d |
| Art Unit | Apps |
|---|---|
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18273700 | TOPICAL FORMULATION CONTAINING DISPERSED PREGABALIN | BARSKY, JARED | 1628 | §103DP | Final Rejection | 14d | Pending | Jul 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial